Black box warnings on Risperdal

Resource 4 Risperdal Info > Black box warnings on Risperdal

Black box warnings on Risperdal

In April of 2005, the FDA determined that the use of Risperdal among elderly patients with dementia is associated with increased mortality. This was in response to more than a dozen placebo-controlled experimental trials with several atypical antipsychotic medications.

As a result of this determination, the agency requested that the manufacturers of Risperdal include a black box warning on the drug. This warning is in regards to patients suffering from dementia, a condition for which the drug is not approved.

Black box warnings are the most serious warnings incorporated into the labeling of a prescription medication. In addition to their role in informing patients of serious health risks, black box warnings also serve to prevent drug manufacturers from advertising their product’s availability to healthcare professionals.

First Name
Last Name
Phone - -
Email
Address
Zip
Comments
By clicking the "Submit" button below, you agree that law firms you are matched with may contact you by telephone even if you are on a federal or state Do Not Call registry. Up to 10 law firms may respond to your request within approximately 2 weeks. In some cases 3 or more firms may respond to your request after 30 days. Use of this site is subject to our Terms of Use.

By leaving this box checked, I agree to receive future advertisements and announcements from our firm, its affiliates and partners.
I agree that submitting this form and the information contained within does not establish an attorney client relationship.
I agree that my information will be reviewed by more than one attorney and/or law firm.
I agree that the information that I will receive in response to the above question is general information and I will not be charged for the response to this e-mail question and I further understand that the law for each state may vary, and therefore, I will not rely upon this information as legal advice. Since this matter may require advice regarding my home state, I agree that local counsel may be contacted for referral of this matter.
By clicking the Submit button, I agree to wiselawgroup’s Privacy Policy and Terms and Conditions and I am also providing my express consent to receive pre-recorded marketing messages from wiselawgroup, it’s affiliates and partners as set forth here.

Black box warnings on Risperdal

Black box warnings on Risperdal

Home